Sun Pharmaceutical Industries has informed that on account of increasing strategic importance of the group's business interests in North and South America, Kalyanasundaram Subramanian, now directly responsible for these businesses, shall soon relocate to the USA. Hence, he has resigned as the director of the company with effect from the March 31, 2012.
The above information is part of company’s filing submitted to the BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1786.90 |
| Dr. Reddys Lab | 1271.05 |
| Cipla | 1384.75 |
| Zydus Lifesciences | 1087.90 |
| Lupin | 2269.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: